The purpose of the combined M.D., Ph.D. program is to provide to a select group of aspiring physician scientists the broad biomedical background and clinical insights of a physician as well as the rigorous research training in a specific scientific discipline that is characteristic of a basic science Ph.D. Graduates of this program are uniquely equipped to apply the most sophisticated and up-to-date methodologies to the study of medical problems, to recognize those areas of medicine where fundamental research is needed and problems are amenable to current experimental analysis. They are also exceptionally well-qualified to serve as medical school faculty, imparting to medical students the importance of acquiring a fundamental understanding of basic science concepts in order to function most effectively as a physician. Their presence also serves to bridge the potential gulf between clinicians, who may lack the scientific training required to elucidate basic pathogenetic mechanisms, and basic scientists who lack the clinical training that may be required to fully realize the potential relevance of their research in elucidating mechanisms of disease. Finally, graduates of this program are expected to assume leadership positions in academic medicine, the pharmaceutical and biotechnology industries and in biomedical research.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007308-30
Application #
6764006
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Shapiro, Bert I
Project Start
1975-07-01
Project End
2008-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
30
Fiscal Year
2004
Total Cost
$1,226,209
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Pushalkar, Smruti; Hundeyin, Mautin; Daley, Donnele et al. (2018) The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov 8:403-416
Weber, Hannah; Garabedian, Michael J (2018) The mediator complex in genomic and non-genomic signaling in cancer. Steroids 133:8-14
Mitre, Mariela; Minder, Jessica; Morina, Egzona X et al. (2018) Oxytocin Modulation of Neural Circuits. Curr Top Behav Neurosci 35:31-53
Dixit, Dhaval; Schwab, Susan R (2018) PreB cells are moving on. J Exp Med 215:2483-2484
Garcia-Bermudez, Javier; Baudrier, Lou; La, Konnor et al. (2018) Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat Cell Biol 20:775-781
Tirko, Natasha N; Eyring, Katherine W; Carcea, Ioana et al. (2018) Oxytocin Transforms Firing Mode of CA2 Hippocampal Neurons. Neuron 100:593-608.e3
Collins, David P; Anastasiades, Paul G; Marlin, Joseph J et al. (2018) Reciprocal Circuits Linking the Prefrontal Cortex with Dorsal and Ventral Thalamic Nuclei. Neuron 98:366-379.e4
Berger, Stephen L; Leo-Macias, Alejandra; Yuen, Stephanie et al. (2018) Localized Myosin II Activity Regulates Assembly and Plasticity of the Axon Initial Segment. Neuron 97:555-570.e6
Wong, Serre-Yu; Coffre, Maryaline; Ramanan, Deepshika et al. (2018) B Cell Defects Observed in Nod2 Knockout Mice Are a Consequence of a Dock2 Mutation Frequently Found in Inbred Strains. J Immunol 201:1442-1451
Blake, Kimbria J; Baral, Pankaj; Voisin, Tiphaine et al. (2018) Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314. Nat Commun 9:37

Showing the most recent 10 out of 265 publications